Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4092194
Max Phase: Preclinical
Molecular Formula: C19H26N2
Molecular Weight: 282.43
Molecule Type: Small molecule
Associated Items:
ID: ALA4092194
Max Phase: Preclinical
Molecular Formula: C19H26N2
Molecular Weight: 282.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc2[nH]c3c(c2c1)CCC(NC1CCC(C)C1)C3
Standard InChI: InChI=1S/C19H26N2/c1-12-3-5-14(9-12)20-15-6-7-16-17-10-13(2)4-8-18(17)21-19(16)11-15/h4,8,10,12,14-15,20-21H,3,5-7,9,11H2,1-2H3
Standard InChI Key: CIIXPQMLJXFNRU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 282.43 | Molecular Weight (Monoisotopic): 282.2096 | AlogP: 4.11 | #Rotatable Bonds: 2 |
Polar Surface Area: 27.82 | Molecular Species: BASE | HBA: 1 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.56 | CX LogP: 4.31 | CX LogD: 1.41 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.85 | Np Likeness Score: -0.41 |
1. Kulkarni MR, Mane MS, Ghosh U, Sharma R, Lad NP, Srivastava A, Kulkarni-Almeida A, Kharkar PS, Khedkar VM, Pandit SS.. (2017) Discovery of tetrahydrocarbazoles as dual pERK and pRb inhibitors., 134 [PMID:28431342] [10.1016/j.ejmech.2017.02.062] |
Source(1):